EyePoint Pharmaceuticals EYPT reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
EyePoint Pharmaceuticals reported in-line EPS of $-0.52 versus an estimate of $-0.52.
Revenue was up $2.55 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 6.92% drop in the share price the next day.
Here's a look at EyePoint Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.58 | -0.53 | -0.40 | -0.43 |
EPS Actual | -0.56 | -0.59 | -0.58 | -0.42 |
Revenue Estimate | 9.89M | 9.80M | 9.84M | 9.13M |
Revenue Actual | 9.29M | 11.54M | 9.06M | 9.01M |
To track all earnings releases for EyePoint Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.